购物车
- 全部删除
- 您的购物车当前为空
Linsidomine hydrochloride (SIN-1 chloride) 是莫西多明的代谢产物,具有舒张血管、抑制血小板聚集和抗心绞痛的活性。在心肌缺血-再灌注模型中,Linsidomine hydrochloride 减少心肌坏死和再灌注诱导的内皮功能障碍,与海绵体的作用机制涉及一氧化氮的释放有关。
Linsidomine hydrochloride (SIN-1 chloride) 是莫西多明的代谢产物,具有舒张血管、抑制血小板聚集和抗心绞痛的活性。在心肌缺血-再灌注模型中,Linsidomine hydrochloride 减少心肌坏死和再灌注诱导的内皮功能障碍,与海绵体的作用机制涉及一氧化氮的释放有关。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 262 | 现货 | |
5 mg | ¥ 597 | 现货 | |
10 mg | ¥ 998 | 现货 | |
25 mg | ¥ 1,790 | 现货 | |
50 mg | ¥ 2,680 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 618 | 现货 |
产品描述 | Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release. |
体外活性 | SIN-1 在心肌缺血-再灌注模型中减少心肌坏死和再灌注引起的内皮功能障碍[1][2]。 |
体内活性 | SIN-1 (chloride) 是莫索明的活性代谢产物。它显示出强大的血管舒张效应和抑制血小板聚集的功能。[1]在心肌缺血-再灌注模型中,SIN-1(氯化物)能降低心肌坏死和减轻再灌注引起的内皮功能障碍。[2] |
别名 | 林西多明盐酸盐, SIN-1 chloride |
分子量 | 206.63 |
分子式 | C6H11ClN4O2 |
CAS No. | 16142-27-1 |
Smiles | Cl.NC1=CN(NO1)N1CCOCC1 |
密度 | 1.303 g/cm3 at 20℃ |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 22.5 mg/mL (108.9 mM), Sonication and heating to 60℃ are recommended. H2O: 45.0 mg/mL (217.8 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容